The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis-Reference-Cited by-同舟云学术

The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis

Published:1985-01 Issue:2 Volume:5 Page:69-72
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Löw A.,Hotze A.,Krapf F.,Schranz W.,Manger B. J.,Mahlstedt J.,Wolf F.,Kalden J. R.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/BF00270299.pdf

Reference19 articles.

1. Skoog WA, Adams WS (1959) Plasmapheresis in a case of Waldenstroem's macroglobulinemia. Clin Res 7:96–101

2. Kalden JR, Schranz W, Lösch G, Krapf F, Bartels O (1982) Neue Indikationsgebiete zur hochdosierten Immunglobulin-therapie: Therapeutischer Plasmaaustausch, Autoimmunopathien. Beitr Infusionsther Klinis Ernähr 9:48–59

3. Jones JV (1982) Plasmapheresis in SLE. Clin Rheum Dis 8:243–268

4. Hunziker ThH, Schwarzenbach HR, Krebs A, Nydegger UE, Champonovo F, Hess M (1979) Plasmaaustausch bei Pemphigus vulgaris. Schweiz Med Wochenschr 111:1637–1646

5. Dandona P, Marshall N, Bidney S, Nathan AW, Harvard CWH (1979) Exophtalmos and pretibial myxoedema not responding to plasmapheresis. Br Med J II:667–679

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Exchange for Kidney Disease: What Is the Best Evidence?;Advances in Chronic Kidney Disease;2014-03

2. Plasmapheresis;Core Concepts in Parenchymal Kidney Disease;2013-07-18

3. Specialized Treatment Approaches and Niche Therapies for Lupus Subsets;Dubois' Lupus Erythematosus and Related Syndromes;2013

4. Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach;Journal of Artificial Organs;2010-12-10

5. New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies;Critical Care Clinics;2002-10